Phase 3 trials
Scope
Date
~
-
Tech, Media & Telecom
Ideahub to launch new platform for individual investors of patents in Q1
In the next three months, South Korea's Ideahub is poised to launch a platform on which individual investors can also invest in patents.If all goes ...
Jan 03, 2023 (Gmt+09:00)
-
Venture capital
Document tool company Business Canvas secures Series A2 round
Business Canvas, a South Korean SaaS (software as a service) startup that services the global document tool "Typed," announced on Tuesday that it ha...
Jan 02, 2023 (Gmt+09:00)
-
Logistics
Korea's Traders Wholesale Club launches paid membership program
S.Korea's big-box store Traders Wholesale Club officially launched its paid membership program called Traders Club on Sunday.The store has secured...
Jan 02, 2023 (Gmt+09:00)
-
Pension funds
Korea’s NPS to be in red in 2022 with 5.3% loss in Jan-Oct
South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...
Jan 01, 2023 (Gmt+09:00)
-
Chemical Industry
Doosan Corp. starts building flexible copper-clad layer plant
South Korea's Doosan Corp. is expanding its production line for flexible cooper-clad layers (FCCL) to boost competitiveness in electronic materials ...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Corporate strategy
CJ ENM sets up brand incubator Brandworks Korea
South Korean entertainment powerhouse CJ ENM Co. plans to foster the brand incubating business and promote sales through Brandworks Korea, the compa...
Dec 26, 2022 (Gmt+09:00)
-
Companies
Samsung Global Goals app rakes in over $10 million in charity 3 years after launch
Samsung Electronics Co. on Monday said Samsung Global Goals, a charity app for the company's Galaxy smartphones and devices, exceeded $10 million in...
Dec 26, 2022 (Gmt+09:00)
-
K-pop
Blackpink's 'How You Like That' video tops 1.3 bn views
K-pop girl group Blackpink's "How You Like That" video has surpassed 1.3 billion views on YouTube, YG Entertainment Inc., the agency representing th...
Dec 23, 2022 (Gmt+09:00)
-
Korean games
Kakao Games to launch Eversoul with 1.3 mn pre-orders
Kakao Games Corp., a game publishing unit of South Korean tech giant Kakao Corp., said on Dec. 23 it will launch the global service of mobile role-p...
Dec 23, 2022 (Gmt+09:00)
-
Automobiles
Hyundai Motor hits 15 mn vehicle sales milestone in US
South Korea’s auto giant Hyundai Motor Co.'s cumulative sales in the US surpassed 15 million units since entering the market in 1986, the comp...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Economy
Vietnam emerges as South Korea's No. 3 trading partner
Vietnam will finish this year as South Korea's No. 3 trading partner and the country with which the latter has the largest trade surplus, a study ha...
Dec 22, 2022 (Gmt+09:00)
-
Korean stock market
Korean holding firms likely to post bigger dividend payouts in 2022
South Korea's major holding companies are expected to set higher dividends per share (DPS) at end-2022 than in previous years, a Samsung Securi...
Dec 20, 2022 (Gmt+09:00)
-
Executive reshuffles
Hyundai becomes younger with 1 in 3 new executives in their 40s
South Korea’s Hyundai Motor Group, which owns Hyundai Motor Co. and Kia Corp., has carried out a year-end mid-tier executive reshuffle marked ...
Dec 20, 2022 (Gmt+09:00)
-
Batteries
LG Energy to spend $3.1 bn on 4680 battery plant in S.Korea
LG Energy Solution Ltd., the world’s No. 2 electric vehicle (EV) battery maker, is poised to spend $3.1 billion on facilities in South Korea t...
Dec 19, 2022 (Gmt+09:00)
-
Automobiles
Hyundai Motor to supply 3,000 vehicles to Libya's disabled
Hyundai Motor Co. said on Sunday that it had signed an agreement to supply vehicles to Libya's disabled through the Social Solidarity Fund, an agenc...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Airlines
Air Busan to resume Busan-Vientiane flights after 3-year hiatus
Air Busan Co. recently expanded the number of flights on its Japan routes and continues to resume flights on its Southeast Asian routes. It will now...
Dec 19, 2022 (Gmt+09:00)
-
Automobiles
Hyundai, Kia to rank third in Europe’s car market after 45 years
Just a couple of decades ago, vehicles built by Hyundai Motor Co. and Kia Corp. were dismissed as second-class cars of poor quality, with some car m...
Dec 16, 2022 (Gmt+09:00)
-
Airlines
Korean Air resumes regular staff recruitment for 1st time in 3 years
Korean Air Lines Co. for the first time in three years has resumed regular staff recruitment that was suspended by the COVID-19 pandemic.Airline ind...
Dec 16, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
LX International wins conditional approval to acquire HanGlas
The Korean Fair Trade Commission said on Monday that it had conditionally approved LX International Corp.'s bid to acquire Hankuk Glass Industries (...
Dec 13, 2022 (Gmt+09:00)
-
Automobiles
Hyundai Motor Group sells hydrogen fuel cell systems to German firm
Hyundai Motor Group will supply a large quantity of hydrogen fuel cell systems to an eco-friendly truck manufacturer in Europe.South Korea's top c...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Research & Development
LG Group seeks future growth engines with new R&D units
LG Group, South Korea’s fourth-largest conglomerate, set up new research and development units at key affiliates to seek future growth engines...
Dec 12, 2022 (Gmt+09:00)